BlossomHill Therapeutics, Inc.

NASDAQ: BLSM · Healthcare · Biotechnology

PublicHQ San Diego, CA · San DiegoCIK 0001839970Reports USD

#1 of 1,418 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 44

v0.1 · 5/100 weight · pillars only

↑ market scale, workforce scale · ↓ listing tenure, filing timeliness

Methodology →

Revenue TTM

—

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

—

Employees

as of 2026-09-08

Market cap

$640.1M

as of 2026-09-08

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is BlossomHill Therapeutics, Inc.’s financial profile?

BlossomHill Therapeutics, Inc. has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

Aura Biosciences, Inc.——GMR Solutions Inc.——Annexon, Inc.——Nuvectis Pharma, Inc.——Bright Minds Biosciences Inc.——Eikon Therapeutics, Inc. Common Stock——

Neighbors

San Diego →

QUALCOMM Incorporated$44.3B79B+Realty Income Corporation$5.7B61C Sempra$12.4B63C DexCom, Inc.$4.7B87A ResMed Inc.$5.1B——Illumina, Inc.$4.3B84B+

Key facts

CEOJing Rong Jean Cui

SectorHealthcare

IndustryBiotechnology

HeadquartersSan Diego, CA

ExchangeNASDAQ: BLSM

Employees63

IPO date2026-08-07

Latest filings

10-Q2026-09-18 8-K2026-09-18 8-K2026-09-15 8-K2026-08-10

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.